These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3805744)

  • 1. Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
    Kuśnierczyk H; Radzikowski C; Paprocka M; Budzyński W; Rak J; Kinas R; Misiura K; Stec W
    J Immunopharmacol; 1986; 8(4):455-80. PubMed ID: 3805744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M; Kuśnierczyk H; Budzyński W; Rak J; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):275-84. PubMed ID: 3592931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds.
    Glazman-Kuśnierczyk H; Matuszyk J; Radzikowski C
    Immunopharmacol Immunotoxicol; 1992; 14(4):883-911. PubMed ID: 1294626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):285-91. PubMed ID: 3592932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
    Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide in experimental tumor systems.
    Goldin A
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):14-23. PubMed ID: 6761864
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
    Struck RF; Schmid SM; Waud WR
    Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide and iphosphamide against Lewis lung carcinoma: evaluation of toxic and therapeutic effects.
    Greco C; Corsi A; Caputo M; Cavallari A; Calabresi F
    Tumori; 1979 Apr; 65(2):169-80. PubMed ID: 462569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of sperm abnormalities in mice by ifosfamide and trofosfamide.
    Quinto I; De Marinis E; De Dominicis G; Della Morte R; Staiano N
    Mutat Res; 1988 Sep; 201(1):113-6. PubMed ID: 3419442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activity of analogues of ifosfamide modified in the N-(2-chloroethyl) group.
    Misiura K; Kinas RW; Stec WJ; Kusnierczyk H; Radzikowski C; Sonoda A
    J Med Chem; 1988 Jan; 31(1):226-30. PubMed ID: 3336021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of selected pharmacological properties of trofosfamide and its enantiomeric derivatives.
    Kleinrok Z; Chmielewska B; Rajtar G; Sawiniec Z; Jarzabek G
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):305-13. PubMed ID: 3592934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of toxicity and therapeutic efficacy of a stabilized cytostatic metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide).
    Klein HO; Wickramanayake PD; Christian E; Coerper C
    Invest New Drugs; 1984; 2(2):191-9. PubMed ID: 6469514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of acute toxicity and antitumor activity of IF-XXV preparation and holoxan.
    Kuśnierczyk H; Matuszyk J; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):547-56. PubMed ID: 2487366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model.
    Wainer IW; Granvil CP; Wang T; Batist G
    Cancer Res; 1994 Aug; 54(16):4393-7. PubMed ID: 8044787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.
    Hohorst HJ; Peter G; Struck RF
    Cancer Res; 1976 Jul; 36(7 PT 1):2278-81. PubMed ID: 945124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Separation and pharmaco-toxicological studies of the enantiomers of Ifosfamide].
    Blaschke G; Hilgard P; Maibaum J; Niemeyer U; Pohl J
    Arzneimittelforschung; 1986 Oct; 36(10):1493-5. PubMed ID: 3814210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of cyclophosphamide and ifosfamide pharmacology.
    Fleming RA
    Pharmacotherapy; 1997; 17(5 Pt 2):146S-154S. PubMed ID: 9322882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism and antitumour activity of the enantiomers of cis- and trans-4-methylcyclophosphamide.
    Farmer PB; Jarman M; Facchinetti T; Pankiewicz K; Stec WJ
    Chem Biol Interact; 1977 Jul; 18(1):47-57. PubMed ID: 890840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trofosfamide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the oral treatment of cancer.
    Wagner A; Hempel G; Boos J
    Anticancer Drugs; 1997 Jun; 8(5):419-31. PubMed ID: 9215603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical toxicology of ifosfamide.
    Barnett D
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):8-13. PubMed ID: 6761867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.